Edward D. Clarkson

1.4k total citations
40 papers, 1.1k citations indexed

About

Edward D. Clarkson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Plant Science. According to data from OpenAlex, Edward D. Clarkson has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 15 papers in Plant Science. Recurrent topics in Edward D. Clarkson's work include Pesticide Exposure and Toxicity (15 papers), Nerve injury and regeneration (12 papers) and Pluripotent Stem Cells Research (8 papers). Edward D. Clarkson is often cited by papers focused on Pesticide Exposure and Toxicity (15 papers), Nerve injury and regeneration (12 papers) and Pluripotent Stem Cells Research (8 papers). Edward D. Clarkson collaborates with scholars based in United States, United Kingdom and Canada. Edward D. Clarkson's co-authors include Curt R. Freed, W. Michael Zawada, Frank S. Adams, Kedar N. Prasad, Judith Edwards‐Prasad, Stanley M. Parsons, Gary A. Rogers, Francisco G. La Rosa, Ben A. Bahr and Susan M. Schulz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Biochemistry.

In The Last Decade

Edward D. Clarkson

40 papers receiving 1.0k citations

Peers

Countries citing papers authored by Edward D. Clarkson

Since Specialization

Citations

This map shows the geographic impact of Edward D. Clarkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward D. Clarkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward D. Clarkson more than expected).

Fields of papers citing papers by Edward D. Clarkson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward D. Clarkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward D. Clarkson. The network helps show where Edward D. Clarkson may publish in the future.

Co-authorship network of co-authors of Edward D. Clarkson

This figure shows the co-authorship network connecting the top 25 collaborators of Edward D. Clarkson. A scholar is included among the top collaborators of Edward D. Clarkson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward D. Clarkson. Edward D. Clarkson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reactive Skin Decontamination Lotion (RSDL) Maintains Its Effectiveness against Cutaneous Applications of VX Nerve Agent for at Least 5 Years Past Its Expiration Date 2018 ·The FASEB Journal ·Edward D. Clarkson, Julia E. Morgan, Paul Chen, Susan M. Schultz, (unknown), Benedict R. Capacio, Irwin Koplovitz	2
2	Female rats are less susceptible during puberty to the lethal effects of percutaneous exposure to VX 2015 ·Toxicology Reports ·(unknown), (unknown), Edward D. Clarkson, Lucille A. Lumley	2
3	Median lethal dose determination for percutaneous exposure to soman and VX in guinea pigs and the effectiveness of decontamination with M291 SDK or SANDIA foam 2012 ·Toxicology Letters ·Edward D. Clarkson, Susan M. Schulz, (unknown), (unknown)	4
4	Butyrylcholinesterase as a therapeutic drug for protection against percutaneous VX 2010 ·Chemico-Biological Interactions ·David E. Lenz, Edward D. Clarkson, Susan M. Schulz, Douglas M. Cerasoli	32
5	Pro-2-PAM therapy for central and peripheral cholinesterases 2010 ·Chemico-Biological Interactions ·James C. DeMar, Edward D. Clarkson, (unknown), Amy J. Campbell, (unknown), Christine A. Herdman, Haim Leader, Susan M. Schulz, (unknown), (unknown), Therese Ku, (unknown), Farhat A. Khan, (unknown), Madhusoodana P. Nambiar, Richard K. Gordon	52
6	Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, Part 1: Guinea pigs challenged with VX 2010 ·Cutaneous and Ocular Toxicology ·(unknown), (unknown), (unknown), (unknown), Edward D. Clarkson	52
7	Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, Part 2: Guinea pigs challenged with soman 2010 ·Cutaneous and Ocular Toxicology ·(unknown), (unknown), (unknown), (unknown), Edward D. Clarkson	24
8	Evaluation of a Barrier Cream against the Chemical Warfare Agent VX using the Domestic White Pig 2005 ·Basic & Clinical Pharmacology & Toxicology ·Robert P. Chilcott, Christopher H. Dalton, Ira Hill, (unknown), (unknown), Edward D. Clarkson, Murray G. Hamilton	31
9	Characterization of cutaneous exposure to chemical warfare agents GD, VX and VR 2001 ·The Society for Neuroscience Abstracts ·Edward D. Clarkson, Brennie E. Hackley, (unknown), (unknown), Susan M. Schulz, (unknown), (unknown), (unknown)	1
10	Fetal Tissue Transplantation for Patients with Parkinson??s Disease 2001 ·Drugs & Aging ·Edward D. Clarkson	36
11	Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons 2001 ·Brain Research ·W. Michael Zawada, Mary Kay Meintzer, Pravin Rao, (unknown), Xiaomin Wang, James E. Esplen, Edward D. Clarkson, Curt R. Freed, Kim A. Heidenreich	38
12	Development of fetal neural transplantation as a treatment for Parkinson's disease 1999 ·Life Sciences ·Edward D. Clarkson, Curt R. Freed	26
13	Brain contains inhibiting factors specific to the large T-antigen gene 1998 ·Cancer Letters ·Edward D. Clarkson, Francisco G. La Rosa, Judith Edwards‐Prasad, Sanjay Kumar, Arun Kumar, William C. Cole, Curt R. Freed, Kedar N. Prasad	5
14	Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats 1998 ·Brain Research ·Edward D. Clarkson, W. Michael Zawada, Frank S. Adams, (unknown), Curt R. Freed	38
15	Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats 1998 ·Nature Medicine ·W. Michael Zawada, (unknown), (unknown), Edward D. Clarkson, Paul J. Golueke, Samir E. Witta, (unknown), J.J. Kane, F. Abel Ponce de Léon, D. Joseph Jerry, James M. Robl, Curt R. Freed, Steven L. Stice	49
16	GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro 1997 ·Cell and Tissue Research ·Edward D. Clarkson, W. Michael Zawada, Curt R. Freed	93
17	Intrastriatal Grafting of Cos Cells Stably Expressing Human Aromatic l‐Amino Acid Decarboxylase: Neurochemical Effects 1997 ·Journal of Neurochemistry ·Farida G. Kaddis, Edward D. Clarkson, Michel Weber, David J. Vandenbergh, David M. Donovan, Jacques Mallet, Philippe Horellou, George R. Uhl, Curt R. Freed	10
18	Classical Noncholinergic Neurotransmitters and the Vesicular Transport System for Acetylcholine 1993 ·Journal of Neurochemistry ·Edward D. Clarkson, Ben A. Bahr, Stanley M. Parsons	4
19	Chapter 20: Acetylcholine transporter — vesamicol receptor pharmacology and structure 1993 ·Progress in brain research ·Stanley M. Parsons, Ben A. Bahr, Gary A. Rogers, Edward D. Clarkson, (unknown), (unknown)	21
20	Binding and Active Transport of Large Analogues of Acetylcholine by Cholinergic Synaptic Vesicles In Vitro 1992 ·Journal of Neurochemistry ·Edward D. Clarkson, Gary A. Rogers, Stanley M. Parsons	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact